ShowcasesPricing
  1. US-listed companies
  2. Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc.APLS

Market cap
$4.9B
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data